Robert Flynn
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
- Family Practice top 5%
Papers in
-
- Medication Adherence and Compliance 3
-
- Pharmacovigilance and Adverse Drug Reactions 4
- Co-authors
- Thomas M. MacDonaldAlex S. F. DoneyRonald S. MacWalterGraham LeeseAndrew D. MorrisRoland JungSandra BonellieGordon Murray
- Journals
- Drug Safety (6 papers)British Journal of Clinical Pharmacology (5 papers)Pharmacoepidemiology and Drug Safety (4 papers)Trials (3 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Robert Flynn
40 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 127
- Nephrology 141
- Family Practice 42
- Endocrinology, Diabetes and Metabolism 301
- Geriatrics and Gerontology 36
- Orthopedics and Sports Medicine 70
Countries citing papers authored by Robert Flynn
This map shows the geographic impact of Robert Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Flynn more than expected).
Fields of papers citing papers by Robert Flynn
This network shows the impact of papers produced by Robert Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Flynn. The network helps show where Robert Flynn may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Flynn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2022 | 4 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 0 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 3 | |
| 10 | 2018 | 13 | |
| 11 | 2017 | 16 | |
| 12 | 2013 | 17 | |
| 13 | 2011 | 3 | |
| 14 | 2010 | 58 | |
| 15 | 2010 | 18 | |
| 16 | 2010 | 8 | |
| 17 | 2009 | 290 | |
| 18 | 2009 | 145 | |
| 19 | 2008 | 170 | |
| 20 | 1993 | 70 |
About Robert Flynn
Robert Flynn is a scholar working on Family Practice, Toxicology, Nephrology, Geriatrics and Gerontology and Gastroenterology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (6 papers), Blood Pressure and Hypertension Studies (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Medication Adherence and Compliance (3 papers). The work is most often cited by research in Nephrology (141 citations), Family Practice (42 citations), Endocrinology, Diabetes and Metabolism (301 citations), Geriatrics and Gerontology (36 citations) and Orthopedics and Sports Medicine (70 citations). Robert Flynn has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Thomas M. MacDonald, Alex S. F. Doney, Ronald S. MacWalter, Graham Leese, Andrew D. Morris, Roland Jung, Sandra Bonellie, Gordon Murray, Michael J. Murphy and Peter T. Donnan. Their work appears in journals such as Drug Safety, British Journal of Clinical Pharmacology, Pharmacoepidemiology and Drug Safety, Trials and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.